AGIO vs QCOM · rev $36.5M vs P/E 16, rev $44.28B
Agios Pharm (AGIO) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported AGIO revenue for 2024-12-31 was $36.5M. Net income was $673.7M. Revenue was up 36.1% from 2023-12-31 to 2024-12-31. AGIO currently screens at market cap $1.68B.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
AGIO currently screens at market cap $1.68B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the AGIO and QCOM stock pages for the full models.
Not investment advice.